CamGene Therapeutics

CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause.

Its lead approach uses an LNP-mRNA growth factor therapeutic designed to regenerate cochlear nerve cells and reduce inflammation, aiming to restore hearing rather than simply manage symptoms as current devices do.

The company operates from its own laboratory at Mill SciTech Park, Hauxton, near Cambridge.